Cash Flow Statement
Quarterly Data

The cash flow statement provides information about a company cash receipts and cash payments during an accounting period, showing how these cash flows link the ending cash balance to the beginning balance shown on the company balance sheet.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

Cigna Group, consolidated cash flow statement (quarterly data)

US$ in millions

3 months ended:	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Net income (loss)	1,536)	825)	1,629)	(212)	1,107)	1,449)	1,510)	1,306)	1,198)	2,778)	1,572)	1,198)	1,133)	1,635)	1,476)	1,171)	4,142)	1,398)	1,760)	1,189)
Depreciation and amortization	646)	650)	738)	741)	765)	766)	755)	749)	735)	726)	759)	717)	743)	734)	731)	715)	713)	702)	694)	693)
Realized investment (gains) losses, net	(68)	921)	48)	1,836)	34)	14)	(26)	56)	—)	81)	95)	319)	(68)	(68)	(59)	(1)	(167)	(32)	(38)	88)
Deferred income tax benefit	256)	(152)	(97)	(102)	(1,356)	(96)	(99)	(108)	(180)	(133)	(29)	(138)	(116)	(24)	(45)	(35)	(46)	(81)	(98)	(161)
(Gain) loss on sale of businesses	(130)	87)	—)	19)	1,478)	21)	—)	—)	73)	(1,735)	—)	—)	—)	—)	—)	—)	(4,203)	—)	—)	—)
Debt extinguishment costs	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	10)	131)	—)	—)	14)	185)
Accounts receivable, net	3,231)	(3,287)	(4,626)	(2,687)	253)	(772)	(665)	(479)	102)	430)	(1,786)	(983)	1,196)	(806)	(1,813)	(1,420)	1,314)	(689)	(1,065)	(1,056)
Inventories	(1,609)	105)	(543)	1,015)	(1,228)	97)	(303)	566)	(759)	(237)	(281)	222)	(702)	21)	(123)	247)	(509)	55)	(146)	96)
Reinsurance recoverable and Other assets	(127)	201)	(627)	68)	(820)	172)	37)	72)	(365)	167)	(242)	402)	(193)	70)	(513)	(20)	635)	(563)	199)	(348)
Insurance liabilities	(377)	(89)	(657)	532)	(898)	(245)	194)	1,533)	(690)	507)	78)	396)	104)	186)	234)	443)	101)	257)	142)	341)
Pharmacy and other service costs payable	(222)	1,159)	3,183)	4,637)	(220)	703)	1,008)	539)	392)	244)	1,198)	(74)	604)	234)	708)	415)	807)	429)	1,247)	408)
Accounts payable and Accrued expenses and other liabilities	1,957)	(804)	1,053)	(1,068)	2,144)	699)	(52)	690)	1,349)	359)	(168)	34)	1,334)	232)	(1,006)	(637)	1,378)	(662)	322)	308)
Other, net	119)	430)	164)	61)	208)	18)	133)	104)	244)	96)	48)	(63)	240)	(95)	104)	84)	129)	81)	243)	144)
Net changes in assets and liabilities, net of non-operating effects	2,972)	(2,285)	(2,053)	2,558)	(561)	672)	352)	3,025)	273)	1,566)	(1,153)	(66)	2,583)	(158)	(2,409)	(888)	3,855)	(1,092)	942)	(107)
Adjustments to reconcile net income (loss) to net cash provided by operating activities	3,676)	(779)	(1,364)	5,052)	360)	1,377)	982)	3,722)	901)	505)	(328)	832)	3,142)	484)	(1,772)	(78)	152)	(503)	1,514)	698)
Net cash provided by operating activities	5,212)	46)	265)	4,840)	1,467)	2,826)	2,492)	5,028)	2,099)	3,283)	1,244)	2,030)	4,275)	2,119)	(296)	1,093)	4,294)	895)	3,274)	1,887)
Debt securities and equity securities	287)	176)	125)	268)	321)	111)	450)	196)	338)	167)	482)	757)	978)	200)	474)	378)	245)	400)	882)	756)
Proceeds from investments sold	287)	176)	125)	268)	321)	111)	450)	196)	338)	167)	482)	757)	978)	200)	474)	378)	245)	400)	882)	756)
Debt securities and equity securities	254)	171)	235)	179)	257)	213)	245)	257)	203)	261)	407)	456)	363)	593)	344)	328)	422)	332)	357)	408)
Commercial mortgage loans	109)	42)	33)	4)	100)	4)	78)	4)	25)	4)	4)	65)	53)	31)	24)	72)	5)	4)	5)	5)
Other sales, maturities and repayments, primarily short-term and other long-term investments	185)	116)	179)	272)	133)	140)	153)	160)	133)	161)	266)	479)	675)	364)	533)	364)	489)	422)	318)	346)
Investment maturities and repayments	548)	329)	447)	455)	490)	357)	476)	421)	361)	426)	677)	1,000)	1,091)	988)	901)	764)	916)	758)	680)	759)
Debt securities and equity securities	(443)	(450)	(313)	(180)	(329)	(666)	(545)	(2,794)	(299)	(433)	(778)	(1,246)	(811)	(743)	(1,019)	(980)	(1,448)	(1,167)	(976)	(1,174)
Commercial mortgage loans	—)	(2)	(20)	(32)	(24)	(35)	(59)	—)	(77)	—)	(25)	(59)	(94)	(104)	(129)	—)	(58)	(42)	(13)	—)
Other, primarily short-term and other long-term investments	(281)	(163)	(271)	(594)	(314)	(206)	(308)	(377)	(454)	(260)	(424)	(425)	(786)	(632)	(499)	(637)	(490)	(500)	(554)	(380)
Investments purchased or originated	(724)	(615)	(604)	(806)	(667)	(907)	(912)	(3,171)	(830)	(693)	(1,227)	(1,730)	(1,691)	(1,479)	(1,647)	(1,617)	(1,996)	(1,709)	(1,543)	(1,554)
Property and equipment purchases, net	(337)	(399)	(370)	(300)	(365)	(403)	(397)	(408)	(345)	(338)	(324)	(288)	(304)	(350)	(258)	(242)	(319)	(252)	(256)	(267)
Acquisitions, net of cash acquired	1)	(132)	—)	—)	(4)	(443)	—)	—)	—)	—)	—)	—)	3)	—)	(1,836)	—)	(4)	(135)	—)	—)
Divestitures, net of cash sold	521)	—)	—)	—)	—)	(14)	5)	22)	(3)	4,895)	—)	(57)	—)	(61)	—)	—)	5,592)	—)	—)	—)
Renewable energy tax credit equity investments	(1,030)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)
Other, net	543)	(135)	(238)	(112)	(215)	(38)	(36)	(43)	(137)	(11)	(16)	(6)	46)	(8)	59)	—)	(14)	—)	—)	37)
Net cash (used in) provided by investing activities	(191)	(776)	(640)	(495)	(440)	(1,337)	(414)	(2,983)	(616)	4,446)	(408)	(324)	123)	(710)	(2,307)	(717)	4,420)	(938)	(237)	(269)
Deposits and interest credited to contractholder deposit funds	46)	36)	41)	43)	40)	31)	51)	45)	43)	37)	41)	43)	21)	36)	49)	47)	254)	240)	262)	267)
Withdrawals and benefit payments from contractholder deposit funds	(48)	(45)	(70)	(65)	(84)	(39)	(52)	(48)	(59)	(67)	(45)	(49)	(29)	(43)	(61)	(35)	(243)	(253)	(228)	(255)
Net change in short-term debt	(768)	833)	(103)	(364)	(286)	1,301)	192)	(9)	(8)	(1,807)	219)	(463)	(658)	1,161)	1,502)	(1,030)	(532)	1,545)	(773)	(180)
Net proceeds on issuance of term loan	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	1,398)	—)
Repayment of term loan	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	(1,400)	—)	—)	—)
Payments for debt extinguishment	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	(10)	(126)	—)	—)	(20)	(192)
Repayment of long-term debt	—)	—)	(790)	(2,210)	—)	(2,887)	—)	(80)	(500)	—)	—)	—)	—)	—)	(379)	(4,199)	(1,150)	(2,099)	(589)	(4,209)
Net proceeds on issuance of long-term debt	—)	—)	—)	4,462)	—)	—)	—)	1,491)	—)	—)	—)	—)	—)	—)	(2)	4,262)	—)	—)	(5)	3,470)
Repurchase of common stock	(2,022)	—)	(990)	(4,022)	(544)	(624)	(154)	(962)	(1,733)	(3,500)	(1,006)	(1,368)	(1,421)	(2,611)	(916)	(2,794)	(1,690)	(1,028)	(368)	(956)
Issuance of common stock	22)	62)	40)	181)	74)	54)	29)	30)	72)	100)	124)	93)	25)	11)	86)	204)	137)	10)	76)	153)
Common stock dividend paid	(384)	(390)	(392)	(401)	(358)	(362)	(362)	(368)	(334)	(341)	(352)	(357)	(324)	(330)	(342)	(345)	—)	—)	(15)	—)
Other, net	(94)	(57)	(45)	(153)	(92)	(46)	(139)	(136)	(117)	61)	103)	(70)	15)	48)	11)	(35)	(97)	(97)	(50)	84)
Net cash used in financing activities	(3,248)	439)	(2,309)	(2,529)	(1,250)	(2,572)	(435)	(37)	(2,636)	(5,517)	(916)	(2,171)	(2,371)	(1,728)	(62)	(4,051)	(4,721)	(1,682)	(312)	(1,818)
Effect of foreign currency rate changes on cash, cash equivalents and restricted cash	(26)	18)	(3)	(9)	14)	(7)	4)	5)	12)	(18)	(57)	(23)	(19)	(19)	(1)	(26)	48)	8)	22)	(37)
Net increase (decrease) in cash, cash equivalents and restricted cash	1,747)	(273)	(2,687)	1,807)	(209)	(1,090)	1,647)	2,013)	(1,141)	2,194)	(137)	(488)	2,008)	(338)	(2,666)	(3,701)	4,041)	(1,717)	2,747)	(237)

Net Income (Loss)

The net income displays considerable volatility over the analyzed quarters, with significant peaks notably in December 2020 and subsequent fluctuations thereafter. A notable decline occurred in the first quarter of 2024 followed by a partial recovery in the middle of 2024, indicating variability in profitability.

Depreciation and Amortization

Depreciation and amortization expenses show a steady incremental trend with only minor fluctuations, reflecting consistent capital asset utilization and amortization practices over time.

Realized Investment Gains and Losses

The realized investment gains and losses exhibit considerable variability with sharp negative and positive swings, including a substantial gain in late 2023, followed by large gains and losses in 2024, suggesting fluctuating investment performance or market conditions.

Deferred Income Tax Benefit

Deferred income tax benefits mostly remain negative with occasional sharp declines, including a significant negative value in late 2023, which may imply episodic tax adjustments or changes in deferred tax assets/liabilities.

Accounts Receivable, Net

Accounts receivable net values show sharp oscillations ranging from large negative to positive amounts, indicating notable changes in billing, collections, or credit policies across quarters, with no clear persistent trend.

Inventories

Inventory levels fluctuate with alternating positive and negative values, reflecting variable inventory management or demand shifts. Extreme values are observed notably in late 2021 and early 2024, signaling episodic inventory adjustments.

Reinsurance Recoverable and Other Assets

This category also shows pronounced volatility with both positive and negative balances scattered over time, suggesting unstable recoverables or asset revaluations possibly linked to underwriting outcomes.

Insurance Liabilities

Insurance liabilities present irregular changes, with some quarters exhibiting increases and others decreases, including large negative values in late 2021 and 2022, indicating fluctuations in claims reserves or underwriting provisions.

Pharmacy and Other Service Costs Payable

These costs generally reflect a cyclical pattern with sporadic large positive spikes in mid-2022 and 2024, suggesting variable expense recognition related to pharmacy and other service arrangements.

Accounts Payable and Accrued Expenses

Accounts payable and accrued expenses show alternating positive and negative values with considerable swings, indicating periods of accelerated payments or accrual reversals.

Net Changes in Assets and Liabilities

There is significant variability in net changes of assets and liabilities, with pronounced positive peaks in several quarters, notably December 2020 and March 2023, and sharp negative dips in others, revealing dynamic operational cash flow management.

Adjustments to Reconcile Net Income to Cash Provided by Operating Activities

These adjustments are highly fluctuating, showing both negative and positive extremes over the periods, which imply considerable non-cash charges or timing differences affecting operating cash flow calculations.

Net Cash Provided by Operating Activities

The operating cash flow demonstrates a generally positive trend with some fluctuations, including strong inflows in key quarters such as December 2020, December 2021, and early 2023. A notable dip occurred in mid-2021, with partial recovery thereafter.

Investment Activities

Investment-related cash flows exhibit substantial volatility:

Proceeds and Sales: Proceeds from investments sold fluctuate widely, including very large inflows in late 2022, indicating active portfolio repositioning.
Purchases and Acquisitions: Purchases and acquisitions reflect sustained investment activity with some quarters showing pronounced increases in expenditures, particularly in early 2023.
Net Cash Used in Investing Activities: Net investing activities cash flows generally show negative outflows with sporadic sharp inflows, notably the strong inflow in December 2020 due to divestitures, signaling strategic asset sales.

Financing Activities

Financing cash flows are predominantly negative across many quarters, reflecting consistent debt repayments, stock repurchases, and dividend payments. Noteworthy are occasional inflows indicative of new debt issuances or stock issuances, but these are generally outweighed by outflows. The repurchase of common stock is significant, peaking in late 2022 and early 2024, indicating aggressive capital return strategies.

Effect of Foreign Currency Rate Changes

The impact of foreign exchange rate changes is relatively minor compared to other cash flow components, oscillating between small positive and negative values, with no clear trend.

Overall Cash Position Trends

Overall, the net increase or decrease in cash and equivalents reveals considerable quarter-to-quarter volatility, with substantial increases at certain points like mid-2020 and early 2023, coupled with sharp declines in other periods such as early 2021 and mid-2024, indicating fluctuating liquidity conditions influenced by the combined effects of operating, investing, and financing activities.

Download chart

Cigna Group (NYSE:CI)

Cash Flow Statement Quarterly Data

Cash Flow Statement
Quarterly Data